{"altmetric_id":1075290,"counts":{"readers":{"mendeley":2,"citeulike":0,"connotea":0},"total":{"posts_count":1},"twitter":{"unique_users_count":1,"unique_users":["ConcordeMedica"],"posts_count":1}},"citation":{"abstract":"We investigated the seroprevalence of human brucellosis and risk factors in a village in Eastern Anatolia, Turkey, where a brucellosis outbreak among cattle had recently occurred.","abstract_source":"pubmed","altmetric_jid":"4f6fa52c3cf058f610004078","authors":["Aypak C","Altunsoy A","Kutta \u00c7elik A"],"first_seen_on":"2012-11-18T12:23:56+00:00","issns":[],"issue":"5","journal":"Journal of Nippon Medical School","last_mentioned_on":1353241425,"links":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23123390?dopt=Abstract"],"pmid":"23123390","pubdate":"2012-11-07T00:00:00+00:00","publisher_subjects":[{"name":"Medical And Health Sciences","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"subjects":["medicine"],"title":"Epidemiological and clinical aspects of human brucellosis in eastern anatolia.","type":"article","volume":"79","mendeley_url":"http:\/\/www.mendeley.com\/research\/epidemiological-clinical-aspects-human-brucellosis-eastern-anatolia-1"},"altmetric_score":{"score":0.25,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":0.25},"context_for_score":{"all":{"total_number_of_other_articles":3619418,"mean":4.9283821178971,"rank":2903713,"this_scored_higher_than_pct":1,"this_scored_higher_than":71801,"rank_type":"exact","sample_size":3619418,"percentile":1},"similar_age_3m":{"total_number_of_other_articles":275230,"mean":5.6620168804888,"rank":219830,"this_scored_higher_than_pct":1,"this_scored_higher_than":307,"rank_type":"exact","sample_size":275230,"percentile":1},"this_journal":{"total_number_of_other_articles":68,"mean":1.0723582089552,"rank":40,"this_scored_higher_than_pct":2,"this_scored_higher_than":2,"rank_type":"exact","sample_size":68,"percentile":2},"similar_age_this_journal_3m":{"total_number_of_other_articles":9,"mean":0.54375,"rank":4,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":9,"percentile":1}}},"demographics":{"poster_types":{"member_of_the_public":1},"users":{"twitter":{"cohorts":{"Members of the public":1}},"mendeley":{"by_status":{"Student  > Postgraduate":2},"by_discipline":{"Medicine and Dentistry":1,"Environmental Science":1}}},"geo":{"twitter":{"GB":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/ConcordeMedica\/statuses\/270140234862317568","license":"datasift","citation_ids":[1075290],"posted_on":"2012-11-18T12:23:45+00:00","author":{"name":"Dr Alex Concorde","url":"http:\/\/www.dralexconcorde.info\/#!health-and-medicine\/c224f","image":"https:\/\/pbs.twimg.com\/profile_images\/1248165228\/concorde_medica_cropped__normal.jpg","description":"Dr Alex is creator of a unique 21C Individual Medicine called 'CruX'! This New Paradigm precisely identifies & targets mind\/-body pathways causing unwellness.","id_on_source":"ConcordeMedica","tweeter_id":"250807966","geo":{"lt":54.75844,"ln":-2.69531,"country":"GB"},"followers":3792},"tweet_id":"270140234862317568"}]}}